Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Gizycka, J. Chorostowska-Wynimko, C. Rybacki, E. Wedrowska, J. Golinska, P. Kopinski (Warsaw, Bydgoszcz, Poland). Cytotoxic phenotype of alveolar lymphocytes (AL) in bronchoalveolar lavage fluid (BALF) from non-small cell lung cancer (NSCLC) patients. Eur Respir J 2014; 44: Suppl. 58, 3879

Member's Comments

No comment yet.

Related content which might interest you: Evaluation of IL-33 level in serum and bronchoalveolar lavage fluid of patients with non-small cell lung cancer (NSCLC) Source: International Congress 2014 – Biology and pathology of thoracic tumours Year: 2014 Evaluation of IL-10 level in serum and bronchoalveolar lavage fluid of patients with non-small cell lung cancer (NSCLC) Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer Year: 2013 Inflammasome pathway activation in patients with non-small cell lung cancer (NSCLC): A bronchoalveolar lavage fluid study Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer Year: 2013 TNF-alpha, IL-1 and IL-6 concentration in bronchoalveolar lavage fluid (BALF) of non-small cell lung cancer (NSCLC) Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer Year: 2013 Feroptosis of alveolar macrophages in lung cancer Source: International Congress 2016 – Lung cancer and immune cells: friends or foes? Year: 2016 Cytotoxic phenotype of lymphocytes in bronchoalveolar lavage (BAL) of patients with non-small cell lung cancer (NSCLC) Source: International Congress 2017 – Lung cancer - basic science: the latest results from the bench Year: 2017 Decreased apoptosis rate of alveolar lymphocytes (AL) in patients with stage I-IIA non-small cell lung cancer (NSCLC) Source: International Congress 2014 – Biology and pathology of thoracic tumours Year: 2014 Alvolar lymphocytes (AL) in patients with non-small cell lung cancer (NSCLC). Data from tumor-affected lobe Source: International Congress 2015 – Connective tissue disorders Year: 2015 Increased expression of WSX1 on alveolar lymphocytes (AL) in patients with early stage non-small cell lung cancer (NSCLC). Preliminary report Source: International Congress 2014 – Biology and pathology of thoracic tumours Year: 2014 Matrix metalloproteinase-9 (MMP-9) elevated in serum, but not in bronchial lavage in lung cancer patients Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer Year: 2013 Surfactant changes in patients with lung cancer underwent to resection Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases Year: 2014 Interleukin 27 (IL27) as antitumor tool? Results from bronchoalveolar lavage (BAL) examination Source: International Congress 2016 – Lung cancer and immune cells: friends or foes? Year: 2016 The level of bronchoalveolar lavage fluid prostaglandine E2; Is it diagnostic of bronchogenic carcinoma? Source: Annual Congress 2013 –Progress in bronchoscopy and pathology techniques for diagnosis of thoracic malignancies Year: 2013 Evaluation of IL-6 level in serum and bronchoalveolar lavage fluid of patients with non-small cell lung cancer (NSCLC) Source: Annual Congress 2011 - Biomarkers and other new methods for lung cancer Year: 2011 Differences in the lipidomic profile of bronchial washing (BW) and bronchoalveolar lavage (BAL) in lung transplanted patients Source: International Congress 2016 – Post-transplant complications: from animal models to the bedside Year: 2016 Utility of bronchoalveolar lavage in the determination of lung asbestos burden in Barcelona, Spain Source: Annual Congress 2013 –Environmental and occupational respiratory diseases: new exposure assessment methods, experimental exposure in animal and humans and mechanisms Year: 2013 CTLA-4 on regulatory T cells - Regulation of local immune response in lung cancer Source: International Congress 2015 – Biomarkers, immunology and molecular pathology of lung cancer Year: 2015 Transbronchial lung cryobiopsy (TBLC) and bronchoalveolar lavage (BAL) in diagnosis of Intersticial Lung Diseases (ILD) Source: International Congress 2019 – Interventional pulmonology techniques: targeting selective lung tissue Year: 2019 Microparticles as biomarkers of lung injury in human broncho-alveolar lavage fluid Source: International Congress 2014 – Translational studies in COPD Year: 2014 The impact of age on bronchoalveolar lavage (BAL) cytoimmunological pattern in interstitial lung diseases (ILD) and in healthy controls Source: International Congress 2014 – ILDs 4 Year: 2014